💸 High Impact

Rep. Nancy Mace Makes Cannabis Make Sense

In a classic case of "politics as usual," Rep. Nancy Mace (R-SC) has thrown down the gauntlet on marijuana reform, positioning herself as a champion of common sense—or at least what seems like common sense to the majority of Americans. Mace, who is pushing the States Reform Act to federally legalize cannabis, didn't mince words in her latest interview.

But let’s not kid ourselves—Mace isn't just targeting the Democrats. She's also taking a swipe at her own party. According to her, many Republicans are running scared from marijuana reform, paralyzed by fear of being “primaried” or blindsided by outdated polling data. Mace suggests that if they actually checked the pulse of the electorate, they'd find a significant chunk of Republicans, and certainly most Americans, are on board with sensible cannabis policy. It's almost like she’s saying, “Wake up, folks—the numbers are in your favor!”

What’s fascinating here is the strategic pivot. Mace is urging Republicans to embrace marijuana reform, not just as a moral issue—though she does call it the “right moral thing to do”—but also as a winning electoral strategy. It's a double whammy: do good and win votes. Yet, despite the seemingly clear benefits, the GOP's reluctance remains. Why? According to Mace, they’re simply clueless. Many in Congress, she argues, lack a nuanced understanding of the marijuana debate, especially as it relates to the ongoing rescheduling efforts. The real kicker? Mace believes that if Republicans want to keep the House, they'd better get serious about marijuana banking reform, a topic she has been banging the drum about for some time.

But there’s a catch. Mace doesn’t see her States Reform Act gaining any traction in the GOP-controlled House—at least not this year. With the legislative calendar packed and other priorities taking center stage, she’s realistic about the bill’s prospects: they’re at a firm “zero percent.” That said, she's not giving up. Mace plans to use the remainder of the year to educate her colleagues about the bill, hoping to build a coalition of co-sponsors who might push the legislation forward in the future. After all, in politics, today’s “no” can always become tomorrow’s “maybe.”

Looking ahead, if the Biden administration does manage to pull off the rescheduling before the election, Mace hints that her own bill might undergo some tweaks before it's reintroduced. The details of those changes? She's keeping them close to the vest for now.

In the end, Mace’s message is clear: the GOP needs to stop looking backward and start aligning with the will of the people. Because when it comes to marijuana reform, it’s not just about catching up—it’s about getting ahead.

📈 Dog Walkers

Tilray Is Tapping The Arts

Breckenridge Brewery, a Tilray Brands, Inc. darling, is serving up more than just craft beer this fall. Mark your calendar for October 12, 2024, as their On Tap concert series returns, partnering with 97.3 KBCO for a musical feast at their scenic Littleton farmhouse. With Kaleo, Hippo Campus, and Cassandra Lewis headlining, it’s shaping up to be a night where great tunes meet good deeds. The cherry on top? Proceeds will benefit Project C.U.R.E., funneling much-needed medical supplies across the globe. Ryan Workman, Breckenridge's Brand Director, couldn't be more stoked, and honestly, who can blame him? Music, charity, and brews—now that's an investment worth toasting.

Missouri Walks Back Hemp Ban

Missouri's political drama is heating up as Governor Mike Parson accuses Secretary of State Jay Ashcroft of letting personal grudges cloud his judgment. The controversy centers around Parson’s attempt to ban intoxicating hemp products, which Ashcroft denied through emergency rulemaking, citing legal concerns. Parson wasn’t buying it, implying Ashcroft’s refusal was more about post-primary sour grapes than child safety. The governor's executive order, aimed at curbing unregulated psychoactive cannabis products, has sparked debate, particularly after a 600% surge in ER visits for young children. With accusations flying and the ban delayed, Missouri’s hemp industry and political scene are both feeling the heat.

Original Story - GMR

DEA Schedules Hearing For December 2

The DEA has decided to keep the cannabis rescheduling saga suspenseful, adding a December 2 hearing to the mix—conveniently scheduled after the November election. This move follows the Justice Department's March proposal to downgrade cannabis from Schedule I to Schedule III, a shift that many hoped would be more straightforward. But the DEA, never one to rush things, wants to hear more expert opinions before making a decision. The timing suggests this process might drag into the new year, potentially colliding with post-election administrative changes. Even if cannabis does get bumped to Schedule III, it won't be a free pass—federal criminal prohibitions and the FDCA will still loom large. The stakes? High, both for cannabis policy and the upcoming election.

Original Story: MM

🗞️ The News

Missouri Officials Clash Over Hemp Ban Enforcement

DEA Schedules Hearing On Marijuana Rescheduling, Delaying Reform Until After Election

DEA Says It Can Still Arrest People For Marijuana Regardless Of State Legalization, But It’s ‘Not Our Intent’ To Go After Possession Cases

Missouri Officials Clash Over Hemp Ban Enforcement

Breckenridge Brewery Announces Latest Concert Series With Kaleo, Hippo Campus and Cassandra Lewis

📺 YouTube

A Look at Four Unknown Marijuana Stocks | TDR Small Cap Sunday

What we covered:

✅ This video shares the highlights of our summer research, finding four lesser-known marijuana stocks. Today, we review these companies to see if Small Cap Sunday Host Shadd Dales and TDR Lead Analyst Bill McNarland would buy them after analyzing their financial statements.

Here is the review of the companies we found this summer:

👀👀Cannara Biotech Inc. | TSXV: LOVE

✅✅MTL Cannabis Corp | CSE: MTLC

✅✅Avicanna Inc | TSX: AVCN

✅✅ Ayurcann Holdings Corp | CSE: AYUR